Kimberlee Caple
Director/Board Member chez CASTLE BIOSCIENCES, INC.
Fortune : 104 216 $ au 31/03/2024
Profil
Kimberlee S.
Caple is an Independent Director at Castle Biosciences, Inc. and Vice President & GM-Genetic Science Business at Thermo Fisher Scientific, Inc. She previously held positions as VP & GM-Molecular Diagnostics Business Unit at Life Technologies, Inc., Principal at Abbott Diagnostics, Inc., Vice President-Marketing & Business Development at Auxogyn, Inc., and Senior Vice President & GM-Clinical Business at Affymetrix, Inc. She completed her undergraduate degree at Purdue University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CASTLE BIOSCIENCES, INC.
0,02% | 14/07/2023 | 4 705 ( 0,02% ) | 104 216 $ | 31/03/2024 |
Postes actifs de Kimberlee Caple
| Sociétés | Poste | Début |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Director/Board Member | 16/07/2021 |
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | 01/01/2020 |
Anciens postes connus de Kimberlee Caple
| Sociétés | Poste | Fin |
|---|---|---|
| AFFYMETRIX, INC. | Corporate Officer/Principal | 01/01/2016 |
Life Technologies, Inc.
 Life Technologies, Inc. BiotechnologyHealth Technology Life Technologies, Inc. provides essential technologies needed by the biotechnology and biopharmaceutical communities. The company manufactures and markets a breadth of offerings unique in the industry, used in applications of the life sciences discovery, development, and production process | Corporate Officer/Principal | - |
Abbott Diagnostics, Inc.
 Abbott Diagnostics, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - |
Auxogyn, Inc.
 Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | - |
Formation de Kimberlee Caple
| Purdue University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CASTLE BIOSCIENCES, INC. | Health Technology |
| THERMO FISHER SCIENTIFIC | Health Technology |
| Entreprise privées | 4 |
|---|---|
Life Technologies, Inc.
Life Technologies, Inc. BiotechnologyHealth Technology Life Technologies, Inc. provides essential technologies needed by the biotechnology and biopharmaceutical communities. The company manufactures and markets a breadth of offerings unique in the industry, used in applications of the life sciences discovery, development, and production process | Health Technology |
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Abbott Diagnostics, Inc.
Abbott Diagnostics, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA. | Health Technology |
Auxogyn, Inc.
Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Health Technology |
